Sea Forest Surges 25% on ASX Debut: Should You Chase or Wait for Pullback?
Sea Forest (ASX: SEA) delivered one of the strongest ASX IPO debuts of 2025, surging 25 percent to $2.50 in…
West African Resources (ASX: WAF) Plunges 16% on Burkina Faso Stake Talks: Buy the Dip or Exit Now?
West African Resources (ASX: WAF) plunged 16% on Wednesday, closing at A$2.56 after returning from a multi-month trading suspension on…
Temple & Webster Crashes 30% Despite Posting Strong FY25 Growth
Fear Over Fundamentals: Temple & Webster’s Best Update Meets a Brutal Selloff Temple & Webster (ASX:TPW) found itself at the…
Australia’s Inflation Fight Isn’t Over, Energy Shock Pushes Prices Back Above Forecasts
Persistent Price Pressures Return Australia’s full monthly inflation report revealed that price pressures are heating up again, running hotter than…
Electro Optic Systems (ASX: EOS) Shares Surge 10% as Legal Cloud Clears and Drone Tech Deal Lands
EOS Rebounds 10% as Legal Overhang Lifts and Defence Expansion Accelerates Electro Optic Systems (ASX: EOS) released two announcements that…
Why Google Is Dominating the AI Rally While Rivals Stumble
Alphabet’s Rerating Shows the Power of Owning the Full AI Stack Tech stocks have faced a tough month, with the…
Here are 6 ASX 200 stocks with low PE multiples – are they bargain buys?
Here are 6 ASX 200 stocks with low PE multiples! Helia (ASX:HLA): 9.4x for FY26 Helia is a mortgage insurer,…
Alma Metals (ASX:ALM): An aspiring copper developer, hoping to follow in the steps of Caravel
There’s not that many opportunities for investors wanting exposure to potential copper developments, but Alma Metals (ASX:ALM) is one company…
Octava Minerals (ASX: OCT) Starts Drilling at Indium Discovery: Buy Before Q1 2026 Results or Wait for Proof?
Octava Minerals (ASX: OCT) has surged 67% over the past month as the company kicks off drilling at its Federation…
Is Argenica (ASX:AGN) a Contrarian Buy After 64% Collapse and New Validation Data?
Argenica Therapeutics (ASX: AGN) crashed 70% in September after Phase II trial results disappointed, wiping out over $100 million overnight.…
Aroa Biosurgery Delivers $8.9M Cash Swing and First Profit: Buy the Biotech Turnaround?
Aroa Biosurgery (ASX: ARX) just crossed a critical milestone, reporting its first profitable half-year result. The business swung to a…
Bendigo Bank Crashes 8% as 6-Year Money Laundering Scandal Exposed: Time to Sell or Buy the Dip?
Bendigo and Adelaide Bank (ASX: BEN) plunged 8% on November 25, 2025, after AUSTRAC disclosed findings from a Deloitte review…
ASX Digital Entertainment Stocks: Mixed Performance in 2025. Time for Selective Opportunities?
Watching your portfolio fluctuate isn’t fun. Digital entertainment stocks listed on the ASX are experiencing very mixed results right now,…
How Altcoin Season Influences Market Sentiment in Australia
Altcoin season is a phrase that spreads quickly across forums and short videos. Most people use it to describe periods…
Ramsay Health Care’s 10% Rally Signals a Turning Point in Hospital Recovery
Ramsay Health Care Finds Its Pulse Again Today, Ramsay Health Care’s (ASX: RHC) shares are up around 10 % after…